← All diseases Cancer

Chronic lymphocytic leukemia

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (63)Meta-analysis (7)Treatment guideline (3)Phase 3 study (32)Systematic review (13)Randomized trial (8)Clinical trial (588)Review article (208)Early study (phase 1 or 2) (38)Case report (197)Laboratory or animal study (14)Commentary or editorial (62)Retracted publication (2) Studies currently seeking participants only (43)

Filter

Publications and studies (1769)

• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. (2018/03/01) ♡
• Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT. (2018/03/01) ♡
• Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimal management of the young CLL patient. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What is the optimal management of older CLL patients? (2018/03/01) ♡
• Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients. (2018/02/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study. (2018/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry. (2018/02/01) ♡
• Cost-Effectiveness of Ibrutinib Compared With Obinutuzumab With Chlorambucil in Untreated Chronic Lymphocytic Leukemia Patients With Comorbidities in the United Kingdom. (2018/02/01) ♡
• Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia. (2018/02/01) ♡
• Bone marrow stromal cells enhance the survival of chronic lymphocytic leukemia cells by regulating HES-1 gene expression and H3K27me3 demethylation. (2018/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter. (2018/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. How I treat CLL patients with ibrutinib. (2018/01/25) ♡
• The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. (2018/01/15) ♡
• Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients. (2018/01/10) ♡
• Drug-perturbation-based stratification of blood cancer. (2018/01/02) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Left atrial abnormality (LAA) as a predictor of ibrutinib-associated atrial fibrillation in patients with chronic lymphocytic leukemia. (2018/01/02) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. (2018/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Venetoclax: a chance for patients with chronic lymphocytic leukaemia previously treated with ibrutinib. (2018/01/01) ♡
• Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma. (2018/01/01) ♡
• Identification of key miRNA-gene pairs in chronic lymphocytic leukemia through integrated analysis of mRNA and miRNA microarray. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Wnt Signaling in Hematological Malignancies. (2018/01/01) ♡
• Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study. (2018/01/01) ♡
• Computer-aided Drug Designing for the Identification of High-Affinity Small Molecule Targeting CD20 for the Clinical Treatment of Chronic Lymphocytic Leukemia (CLL). (2018/01/01) ♡
• Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia. (2018/01/01) ♡
• Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia. (2017/12/29) ♡
• Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases. (2017/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL). (2017/12/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications. (2017/12/22) ♡
• Efficacy of Rituximab for Patients with Chronic Lymphocytic Leukemia. (2017/12/20) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy. (2017/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ibrutinib-associated pityriasis rosea-like rash. (2017/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Paraneoplastic pemphigus mimicking toxic epidermal necrolysis: An underdiagnosed entity? (2017/12/19) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene. (2017/12/15) ♡
• Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders. (2017/12/15) ♡
• A Challenging Case of Pseudohyperkalemia in Chronic Lymphocytic Leukemia. (2017/12/13) ♡
• Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope. (2017/12/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis. (2017/12/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment-free remission in CML: who, how, and why? (2017/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chronic neutropenia in LGL leukemia and rheumatoid arthritis. (2017/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. (2017/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optimizing frontline therapy of CLL based on clinical and biological factors. (2017/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. How should we sequence and combine novel therapies in CLL? (2017/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Safety profiles of novel agent therapies in CLL. (2017/12/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful pregnancy in the context of previously undiagnosed chronic lymphocytic leukaemia: A case report and literature review. (2017/12/01) ♡
• XVII International Workshop on Chronic Lymphocytic Leukemia 2017 May 12--15, 2017, New York. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia. (2017/12/01) ♡
• [Alteration of IFN-γ, IL-4, IL-17 and TGF-β levels in Serum of Patients with Chronic Lymphocytic Leukemia Treated with FCR]. (2017/12/01) ♡
• CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia. (2017/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.